Protein Sequencing Market - Growth, Trends, and Forecast (2019 - 2024)
|発行||Mordor Intelligence LLP||商品コード||911974|
|出版日||ページ情報||英文 114 Pages
|タンパク質シーケンシングの世界市場：成長、動向、および予測 Protein Sequencing Market - Growth, Trends, and Forecast (2019 - 2024)|
|出版日: 2019年09月01日||ページ情報: 英文 114 Pages||
The major factors for the growth of the protein sequencing market include the rising focus on target-based drug development, and increasing funding for proteomics research.
The rising funding for proteomic research is expected to boost the protein sequencing market over the forecast period. In the United States, the Office of Cancer Clinical Proteomics Research (OCCPR) supports the development of technologies and reagents that will advance understanding of protein biology in cancer. Furthermore, recently on January 2018, more than USD 18 million in funding awarded to two national platforms in which the University of Victoria plays a key role to improve the diagnosis and treatment of various diseases such as cancer and Alzheimer's. In addition, one of the market player Biognosys, on July 2017 announced that it has secured USD 5 million funding from new and existing investors in an extended series C round. Thus, rising funding for proteomic research is expected to propel the overall growth of the market over the forecast period.
As per the scope of this report, protein sequencing is the process of determining the amino acid sequence of all or part of a protein or peptide. This techniques are helpful in the identification of proteins and characterize their post-translational modifications. The market is segmented by products and services, application, end-user, and geography.
Protein Engineering Studies is the Segment by Application expected to be the Fastest-Growing Segment
Protein engineering is the manipulation of the structures of proteins to produce the desired properties or the synthesis of proteins with particular structures. The majority of therapeutic drugs in the current market are bio formulations, such as antibodies, nucleic acid products, and vaccines. The companies are focusing on field in protein engineering for the site-specific conjugation of functional moieties to biopharmaceuticals is the incorporation of unnatural amino acids (uAA). The rapid developments in post-translational engineering and strain development to produce better-defined products, faster approval of biopharmaceuticals can be expected. Furthermore, according to the data published by the Genetics & Protein Engineering Conferences 2018, roughly 3,000 professionals from 60 over universities in the country, currently working on protein engineering. Thus, owing to the rising focus on protein engineering the market is expected to witness high growth.
North America is Expected to Hold Largest Market Share over the Forecast Period
The United States is expected to be the largest protein sequencing market owing to the rising technological advancements and the presence of better healthcare infrastructure. In the United States, the pharmaceutical industry is one of the most research-intensive organizations. And this pharmaceutical industry is deeply invested in applying innovative solutions to enhance the pipeline development to support improvements in patient care. Furthermore, there is a rising focus on target-based drug development and protein sequencing studies helping in target-based drug development. Also, government and non-government organizations are providing funds to carry out research in the field of proteomics. Thus, owing to all above-mentioned factors the market is expected to witness high growth over the forecast period.
The market studied is a fragmented market owing to the presence of various market players. Some of the market players are Agilent Technologies, Inc., Bioinformatics Solutions, Charles River Laboratories, Proteome Factory, Rapid Novor Inc., Selvita SA, SGS SA, Shimadzu Corporation, Thermo Fisher Scientific Inc., and Waters